Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RevHealth does not conduct clinical trials or have clinical results. It provides omnichannel healthcare communications and strategic brand consulting for pharmaceutical, biotech, and medical device companies. The company has launched AgencyOS in partnership with PixieDust Labs to optimize campaign development using AI. It has been recognized as one of the top independent agencies in North America for its creative expertise and industry impact. In July 2022, WindRose Health Investors recapitalized the business to support further growth; founders remain significant shareholders and continue leading the company. Recent leadership changes include Ben Beckley as CEO since 2024. The firm partners with clients across all stages of product lifecycle marketing—from pre-launch strategy through post-market education—helping communicate cutting-edge science and launch novel therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RevHealth.